Kalitabs

Potassium Chloride, the active ingredient in Kalitabs, is a potassium supplement presented as an oral dosage form for oral use. It helps restore normal serum potassium levels and corrects hypokalemia in patients who require electrolyte replacement. GNH USA supplies Kalitabs as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Kalitabs is a potassium supplement used to treat conditions associated with low serum potassium levels. - Hypokalemia: restores normal potassium concentrations and supports muscle and cardiac function. - Potassium deficiency: provides essential potassium ions to correct electrolyte imbalance and prevent related complications.

Kalitabs may cause adverse reactions, most of which are related to gastrointestinal irritation or excess potassium.

Common Side Effects: - Nausea: mild to moderate feeling of sickness. - Vomiting: occasional expulsion of stomach contents. - Abdominal discomfort: cramping or pain in the stomach area. - Diarrhea: loose stools occurring after dosing. - Constipation: reduced bowel movements. - Metallic taste: transient alteration in mouthfeel.

Serious or Rare Side Effects: - Hyperkalemia: dangerously high serum potassium that can affect heart rhythm. - Cardiac arrhythmia: irregular heartbeat potentially leading to serious events. - Severe allergic reaction: rash, itching, swelling, or difficulty breathing. - Muscle weakness: notable loss of strength. - Chest pain: discomfort that may indicate cardiac involvement.

Before using Kalitabs, consider the following safety measures. - Monitor serum potassium: regular blood tests to avoid over‑correction. - Adjust dose in renal impairment: reduced kidney function can increase potassium retention. - Avoid in existing hyperkalemia: contraindicated when potassium levels are already elevated. - Use cautiously in cardiac disease: excess potassium may precipitate arrhythmias. - Review concomitant medications: assess for drugs that affect potassium balance. - Store at ambient temperature: keep below 25 °C in the original container, protected from moisture.

Kalitabs can interact with several medicines that influence potassium balance.

Major Interactions (Avoid): - ACE inhibitors: may cause additive hyperkalemia. - Angiotensin II receptor blockers (ARBs): increase risk of elevated potassium. - Potassium‑sparing diuretics (e.g., spironolactone): can lead to dangerous potassium accumulation. - NSAIDs: may reduce renal potassium excretion.

Moderate Interactions (Monitor Closely): - Digoxin: heightened risk of toxicity with high potassium. - Beta‑blockers: may mask symptoms of hyperkalemia. - Lithium: potassium levels can affect lithium clearance. - Heparin: can impair renal potassium handling.